Alerts will be sent to your verified email
Verify Email
BRAWN
|
Brawn Biotech
|
Malabar Trading
|
EVOQ Remedies
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-23.35 % | n/a | 21.9 % |
|
5yr average Equity Multiplier
|
2.88 | n/a | 3.25 |
|
5yr Average Asset Turnover Ratio
|
1.32 | n/a | 0.54 |
|
5yr Avg Net Profit Margin
|
-8.78 % | n/a | 6.7 % |
|
Price to Book
|
1.89 | n/a | 0.16 |
|
P/E
|
0.0 | n/a | 80.36 |
|
5yr Avg Cash Conversion Cycle
|
109.48 Days | n/a | 149.18 Days |
|
Inventory Days
|
105.98 Days | n/a | 70.89 Days |
|
Days Receivable
|
98.89 Days | n/a | 160.81 Days |
|
Days Payable
|
144.31 Days | n/a | 163.4 Days |
|
5yr Average Interest Coverage Ratio
|
-119.79 | n/a | 2683.3 |
|
5yr Avg ROCE
|
-15.28 % | n/a | 29.29 % |
|
5yr Avg Operating Profit Margin
|
-9.69 % | n/a | -11.9 % |
|
5 yr average Debt to Equity
|
0.0 | n/a | 0.18 |
|
5yr CAGR Net Profit
|
29.32 % | n/a | -34.02 % |
|
5yr Average Return on Assets
|
-7.81 % | n/a | 3.64 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
53.66 % | n/a | 11.21 % |
|
Share Pledged by Promoters
|
0.0 | n/a | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.07 % | n/a | -62.32 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.24 % | n/a | 0.0 |
|
Brawn Biotech
|
Malabar Trading
|
EVOQ Remedies
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|